PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Srinivas Akkaraju joins New Leaf Venture Partners

New Leaf Venture Partners has appointed Srinivas Akkaraju as a managing director and lead of NLV Partners’ West Coast biopharmaceuticals practice.
 

New Leaf Venture Partners has appointed Srinivas Akkaraju as a managing director and lead of NLV Partners’ West Coast biopharmaceuticals practice.
 
Before joining NLV Partners, Akkaraju was a co-founder and managing director of Panorama Capital, having earlier been a partner at J.P. Morgan Partners responsible for leading venture investing in biotech companies.

Previously, he held business and corporate development positions at Genentech, where he was responsible for worldwide partnering activities, in-licensing of therapeutics and out-licensing of development projects. Akkaraju was also a founding member of BioStreet, an online marketplace for biotech opportunities.
 
‘Dr. Akkaraju will be a tremendous addition to NLV Partners, and we are delighted to welcome him to the team,’ says Philippe Chambon, a managing director of NLV Partners. ‘We expect his broad network of contacts and extensive experience in the biopharma industry will prove invaluable for the firm and to our portfolio companies, particularly on the West Coast.’

Akkaraju says: ‘I am excited to join NLV Partners. The depth, quality and cohesiveness of NLV Partners attracted me to the firm, and I look forward to the opportunity to continue developing as an investor in a dynamic and creative environment.’

NLV Partners is a life science-dedicated venture capital firm with offices in Menlo Park and New York. Founded by a team of venture capitalists with deep healthcare industry experience, NLV Partners invests primarily in companies focused on clinical-stage biopharmaceutical products, early-stage medical devices and molecular diagnostics.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured